PHR — Pharmena SA Share News
0.000.00%
Last trade - 00:00- PLN35.75m
- PLN29.30m
- PLN0.27m
Brief: Pharmena Q2 Net Loss Narrows To 1.6 Mln Zlotys
Brief: Pharmena Develops Research Plan For 1-MNA In Viral Infections Including Sars-Cov-2
Brief: Pharmena Q1 Net Loss Widens To 0.8 Mln Zlotys
Brief: Pharmena Expands Cooperation With Amazon EU On Product Distribution
Brief: Pharmena Files For Patent For 1-MNA Use For Use In Viral Infections And Allergies
Brief: Pharmena Says Coronavirus Outbreak May Have Impact On Group's Financial Results
Brief: Pharmena Starts Presentation Of Menavitin Diet Supplements
Brief: Pharmena Sets Effective Dose For 1-MNA Drug In PAH Indication Post Preclinical Study
Brief: Pharmena To Sell Its Products On E-Commerce Amazon Platforms
Brief: Pharmena Q3 Net Result Turns To Loss Of 1.1 Mln Zlotys
Brief: Pharmena Q2 Net Loss Widens To 5.4 Mln Zlotys
Brief: Pharmena Starts Selling Its Products On Chinese T-Mall Internet Platform
Brief: Pharmena Gets Positive Test Results On 1-MNA Drug In NASH Indication
Brief: Pharmena Introduces New Supplement, Menavitin Senior
Brief: Pharmena Launches Sales Of Two More Diet Supplements From Menavitin Line In Poland
Brief: 2.2 Mln E Series Shares Of Pharmena Were Subscribed For At 6 Zlotys/Shr
Brief: Pharmena Series E Shares To Start Trading At Main Market Of WSE
Brief: Pharmena Q1 Net Result Turns To Loss Of 0.5 Mln Zlotys YoY
Brief: Pharmena Launches Sales Of New Batch Of Diet Supplements